Hercules Technology Growth Capital, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC) on June 29, 2005, reporting an event that occurred on that date. The company is a business development company based in Palo Alto, California.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt levels, or liquidity metrics. The only specific financial figure disclosed is a new debt financing commitment of US$10 million.
Material Changes
On June 29, 2005, the company entered into an agreement to provide US$10 million in debt financing to the U.S. Subsidiary of Labopharm, Inc. (TSX: DDS), a Canadian-based entity. This represents a new investment deployment.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors related to this transaction. The event is reported under Item 8.01 (Other Events) with a press release dated July 11, 2005, attached as an exhibit.
Key Facts for Investor Verification
- Verify the terms and interest rate of the US$10 million debt facility provided to Labopharm, Inc.'s U.S. Subsidiary.
- Confirm the impact of this new investment on the company's total portfolio and leverage ratios.
- Review the full text of the July 11, 2005 press release (Exhibit 99.1) for additional deal specifics not included in the 8-K body.